From mechanisms to future therapy: a synopsis of isolated REM sleep behavior disorder as early synuclein-related disease
Parkinson disease (PD), dementia with Lewy bodies (DLB) and multiple system atrophy are synucleinopathies, characterized by neuronal loss, gliosis and the abnormal deposition of α-synuclein in vulnerable areas of the nervous system. Neurodegeneration begins however several years before clinical onse...
| Main Authors: | , , , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
BioMed Central
2025
|
| _version_ | 1824459343971483648 |
|---|---|
| author | Stefani, A Antelmi, E Arnaldi, D Arnulf, I During, E Högl, B Hu, MMT Iranzo, A Luke, R Peever, J Postuma, RB Videnovic, A Gan-Or, Z |
| author_facet | Stefani, A Antelmi, E Arnaldi, D Arnulf, I During, E Högl, B Hu, MMT Iranzo, A Luke, R Peever, J Postuma, RB Videnovic, A Gan-Or, Z |
| author_sort | Stefani, A |
| collection | OXFORD |
| description | Parkinson disease (PD), dementia with Lewy bodies (DLB) and multiple system atrophy are synucleinopathies, characterized by neuronal loss, gliosis and the abnormal deposition of α-synuclein in vulnerable areas of the nervous system. Neurodegeneration begins however several years before clinical onset of motor, cognitive or autonomic symptoms. The isolated form of REM sleep behavior disorder (RBD), a parasomnia with dream enactment behaviors and excessive muscle activity during REM sleep, is an early stage synucleinopathy. The neurophysiological hallmark of RBD is REM sleep without atonia (RWSA), i.e. the loss of physiological muscle atonia during REM sleep. RBD pathophysiology is not fully clarified yet, but clinical and basic science suggest that ɑ-syn pathology begins in the lower brainstem where REM atonia circuits are located, including the sublaterodorsal tegmental/subcoeruleus nucleus and the ventral medulla, then propagates rostrally to brain regions such as the substantia nigra, limbic system, cortex. Genetically, there is only a partial overlap between RBD, PD and DLB, and individuals with iRBD may represent a specific subpopulation. A genome-wide association study identified five loci, which all seem to revolve around the GBA1 pathway. iRBD patients often show subtle motor, cognitive, autonomic and/or sensory signs, neuroimaging alterations as well as biofluid and tissue markers of neurodegeneration (in particular pathologic α-synuclein aggregates), which can be useful for risk stratification. Patients with iRBD represent thus the ideal population for neuroprotective/neuromodulating trials. This review provides insights into these aspects, highlighting and substantiating the central role of iRBD in treatment development strategies for synucleinopathies. |
| first_indexed | 2025-02-19T04:40:17Z |
| format | Journal article |
| id | oxford-uuid:e74fd831-a977-4152-85ba-c2ab42455403 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2025-02-19T04:40:17Z |
| publishDate | 2025 |
| publisher | BioMed Central |
| record_format | dspace |
| spelling | oxford-uuid:e74fd831-a977-4152-85ba-c2ab424554032025-02-13T20:07:19ZFrom mechanisms to future therapy: a synopsis of isolated REM sleep behavior disorder as early synuclein-related diseaseJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:e74fd831-a977-4152-85ba-c2ab42455403EnglishJisc Publications RouterBioMed Central2025Stefani, AAntelmi, EArnaldi, DArnulf, IDuring, EHögl, BHu, MMTIranzo, ALuke, RPeever, JPostuma, RBVidenovic, AGan-Or, ZParkinson disease (PD), dementia with Lewy bodies (DLB) and multiple system atrophy are synucleinopathies, characterized by neuronal loss, gliosis and the abnormal deposition of α-synuclein in vulnerable areas of the nervous system. Neurodegeneration begins however several years before clinical onset of motor, cognitive or autonomic symptoms. The isolated form of REM sleep behavior disorder (RBD), a parasomnia with dream enactment behaviors and excessive muscle activity during REM sleep, is an early stage synucleinopathy. The neurophysiological hallmark of RBD is REM sleep without atonia (RWSA), i.e. the loss of physiological muscle atonia during REM sleep. RBD pathophysiology is not fully clarified yet, but clinical and basic science suggest that ɑ-syn pathology begins in the lower brainstem where REM atonia circuits are located, including the sublaterodorsal tegmental/subcoeruleus nucleus and the ventral medulla, then propagates rostrally to brain regions such as the substantia nigra, limbic system, cortex. Genetically, there is only a partial overlap between RBD, PD and DLB, and individuals with iRBD may represent a specific subpopulation. A genome-wide association study identified five loci, which all seem to revolve around the GBA1 pathway. iRBD patients often show subtle motor, cognitive, autonomic and/or sensory signs, neuroimaging alterations as well as biofluid and tissue markers of neurodegeneration (in particular pathologic α-synuclein aggregates), which can be useful for risk stratification. Patients with iRBD represent thus the ideal population for neuroprotective/neuromodulating trials. This review provides insights into these aspects, highlighting and substantiating the central role of iRBD in treatment development strategies for synucleinopathies. |
| spellingShingle | Stefani, A Antelmi, E Arnaldi, D Arnulf, I During, E Högl, B Hu, MMT Iranzo, A Luke, R Peever, J Postuma, RB Videnovic, A Gan-Or, Z From mechanisms to future therapy: a synopsis of isolated REM sleep behavior disorder as early synuclein-related disease |
| title | From mechanisms to future therapy: a synopsis of isolated REM sleep behavior disorder as early synuclein-related disease |
| title_full | From mechanisms to future therapy: a synopsis of isolated REM sleep behavior disorder as early synuclein-related disease |
| title_fullStr | From mechanisms to future therapy: a synopsis of isolated REM sleep behavior disorder as early synuclein-related disease |
| title_full_unstemmed | From mechanisms to future therapy: a synopsis of isolated REM sleep behavior disorder as early synuclein-related disease |
| title_short | From mechanisms to future therapy: a synopsis of isolated REM sleep behavior disorder as early synuclein-related disease |
| title_sort | from mechanisms to future therapy a synopsis of isolated rem sleep behavior disorder as early synuclein related disease |
| work_keys_str_mv | AT stefania frommechanismstofuturetherapyasynopsisofisolatedremsleepbehaviordisorderasearlysynucleinrelateddisease AT antelmie frommechanismstofuturetherapyasynopsisofisolatedremsleepbehaviordisorderasearlysynucleinrelateddisease AT arnaldid frommechanismstofuturetherapyasynopsisofisolatedremsleepbehaviordisorderasearlysynucleinrelateddisease AT arnulfi frommechanismstofuturetherapyasynopsisofisolatedremsleepbehaviordisorderasearlysynucleinrelateddisease AT duringe frommechanismstofuturetherapyasynopsisofisolatedremsleepbehaviordisorderasearlysynucleinrelateddisease AT hoglb frommechanismstofuturetherapyasynopsisofisolatedremsleepbehaviordisorderasearlysynucleinrelateddisease AT hummt frommechanismstofuturetherapyasynopsisofisolatedremsleepbehaviordisorderasearlysynucleinrelateddisease AT iranzoa frommechanismstofuturetherapyasynopsisofisolatedremsleepbehaviordisorderasearlysynucleinrelateddisease AT luker frommechanismstofuturetherapyasynopsisofisolatedremsleepbehaviordisorderasearlysynucleinrelateddisease AT peeverj frommechanismstofuturetherapyasynopsisofisolatedremsleepbehaviordisorderasearlysynucleinrelateddisease AT postumarb frommechanismstofuturetherapyasynopsisofisolatedremsleepbehaviordisorderasearlysynucleinrelateddisease AT videnovica frommechanismstofuturetherapyasynopsisofisolatedremsleepbehaviordisorderasearlysynucleinrelateddisease AT ganorz frommechanismstofuturetherapyasynopsisofisolatedremsleepbehaviordisorderasearlysynucleinrelateddisease |